Viewing Study NCT04803851


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-25 @ 9:32 PM
Study NCT ID: NCT04803851
Status: UNKNOWN
Last Update Posted: 2023-06-22
First Post: 2021-02-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module